Proteina Co., Ltd. (KOSDAQ:468530)

Market Cap	210.30B
Revenue	n/a
Net Income	n/a
Shares Out	10.78M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,626,228
Average Volume	5,180,829
Open	19,610
Previous Close	19,500
Day's Range	18,540 - 20,850
52-Week Range	13,560 - 25,350
Beta	n/a
RSI	n/a
Earnings Date	n/a

About Proteina

Proteina Co.,Ltd. develops protein-protein interaction profiling technology. The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance. It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information. Proteina Co., Ltd. was founded in 201...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 468530